MAZZEI, TERESITA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.172
EU - Europa 10.630
AS - Asia 8.867
SA - Sud America 1.240
AF - Africa 235
OC - Oceania 216
Continente sconosciuto - Info sul continente non disponibili 5
Totale 37.365
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.007
RU - Federazione Russa 4.120
SG - Singapore 2.540
CN - Cina 2.160
PL - Polonia 1.558
HK - Hong Kong 1.345
IE - Irlanda 1.104
BR - Brasile 986
IT - Italia 953
KR - Corea 894
VN - Vietnam 889
SE - Svezia 838
DE - Germania 481
FI - Finlandia 384
UA - Ucraina 378
FR - Francia 375
IN - India 292
GB - Regno Unito 221
AU - Australia 206
JP - Giappone 172
TR - Turchia 121
JO - Giordania 109
AR - Argentina 105
CA - Canada 78
BD - Bangladesh 67
NG - Nigeria 59
ID - Indonesia 50
MX - Messico 49
ES - Italia 48
CI - Costa d'Avorio 47
IQ - Iraq 46
ZA - Sudafrica 37
CH - Svizzera 35
EC - Ecuador 35
NL - Olanda 32
CO - Colombia 29
BE - Belgio 26
PE - Perù 23
UZ - Uzbekistan 23
VE - Venezuela 22
SA - Arabia Saudita 21
AE - Emirati Arabi Uniti 18
PK - Pakistan 18
CL - Cile 17
MA - Marocco 17
SC - Seychelles 17
PY - Paraguay 13
PH - Filippine 12
JM - Giamaica 10
NZ - Nuova Zelanda 10
AZ - Azerbaigian 9
IR - Iran 9
TN - Tunisia 9
TW - Taiwan 9
AL - Albania 8
AT - Austria 8
CZ - Repubblica Ceca 8
DZ - Algeria 8
KE - Kenya 8
TH - Thailandia 8
BJ - Benin 7
ET - Etiopia 7
LB - Libano 7
LT - Lituania 7
SY - Repubblica araba siriana 7
UY - Uruguay 7
EG - Egitto 6
KZ - Kazakistan 6
BG - Bulgaria 5
CR - Costa Rica 5
GR - Grecia 5
NP - Nepal 5
OM - Oman 5
DO - Repubblica Dominicana 4
HN - Honduras 4
LU - Lussemburgo 4
MK - Macedonia 4
MY - Malesia 4
PS - Palestinian Territory 4
SN - Senegal 4
SV - El Salvador 4
BO - Bolivia 3
BY - Bielorussia 3
DK - Danimarca 3
EU - Europa 3
HU - Ungheria 3
KW - Kuwait 3
PA - Panama 3
PT - Portogallo 3
RS - Serbia 3
AM - Armenia 2
BH - Bahrain 2
EE - Estonia 2
IL - Israele 2
KG - Kirghizistan 2
LV - Lettonia 2
LY - Libia 2
MD - Moldavia 2
NO - Norvegia 2
RO - Romania 2
Totale 37.339
Salva come PNG Salva come JPEG
Città #
Santa Clara 3.889
Singapore 1.757
Warsaw 1.554
Ashburn 1.262
Chandler 1.148
Dublin 1.101
Hong Kong 1.067
Fairfield 1.038
Seoul 861
Jacksonville 680
Hefei 608
Woodbridge 480
Cambridge 465
San Jose 459
Seattle 423
Houston 390
Wilmington 375
Beijing 332
The Dalles 310
Ho Chi Minh City 300
Buffalo 296
Lauterbourg 261
Princeton 259
Los Angeles 237
Ann Arbor 226
Melbourne 202
Hanoi 201
Boston 193
Boardman 185
Mumbai 170
Tokyo 169
Lawrence 151
Altamura 136
Florence 129
Dallas 124
Helsinki 115
Moscow 113
Medford 106
Shanghai 101
New York 100
Munich 95
São Paulo 82
Kent 76
Milan 70
San Diego 63
Izmir 55
Abuja 54
Norwalk 51
Abidjan 47
Guangzhou 47
Council Bluffs 46
Dearborn 46
Redondo Beach 46
Turku 46
Paris 45
Haiphong 43
Da Nang 41
West Jordan 41
Orem 40
Hillsboro 38
Falls Church 36
Rome 36
Clifton 35
Toronto 33
Bremen 32
Rio de Janeiro 31
Bern 28
London 27
Phoenix 27
Bengaluru 26
Brooklyn 25
Frankfurt am Main 25
Chennai 24
Pune 23
Tianjin 23
Auburn Hills 22
Belo Horizonte 22
Yubileyny 22
Brussels 21
Jakarta 20
Tashkent 20
Andover 19
Bologna 18
Denver 18
Dong Ket 18
Montreal 18
Baghdad 17
Biên Hòa 17
Johannesburg 17
Brasília 16
Frankfurt Am Main 16
Redwood City 16
Dhaka 15
Stockholm 15
Buenos Aires 14
Lima 14
Porto Alegre 14
Catania 13
Curitiba 13
Guarulhos 13
Totale 23.904
Salva come PNG Salva come JPEG
Nome #
Cytotoxic activity of 3-nitropyrazolo[5,1-c][1,2,4]benzotriazine derivatives: a new series of anti-proliferative agents. 355
Farmaci antineoplastici - Farmaci inibitori della trasduzione del segnale - Farmaci inibitori di protein chinasi 322
A survey on infection management practices in Italian ICUs 319
Thymidylate synthase expression and genotype have no major impact on the clinical outcome of colorectal cancer patients treated with 5-fluorouracil 316
How to manage aspergillosis in non-neutropenic intensive care unit patients. 291
Bimonthly chemotherapy with oxaliplatin, irinotecan, infusional 5-fluorouracil/folinic Acid in patients with metastatic colorectal cancer pretreated with irinotecan- or oxaliplatin-based chemotherapy. 290
A survey on infection management practices in Italian ICUs. 284
Treatment of extensively drug-resistant Gram-negative infections in critically ill patients: Outcome of a consensus meeting at the 13th Asia-Pacific Congress of Clinical Microbiology and Infection, October 2012 273
Intraoperative positive fluid balance improves tissue diffusion of ceftizoxime. 266
Treatment options for methicillin-resistant Staphylococcus aureus (MRSA) infection: Where are we now? 265
MTHFR-1298 A>C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatin 264
Breakthrough Cancer Pain: Preliminary Data of The Italian Oncologic Pain Multisetting Multicentric Survey (IOPS-MS) 247
Vancomycin in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infection: End of an era? 243
Comportamenti sessuali e contraccezione 232
Marked variation of thymidylate synthase and folylpolyglutamate synthetase gene expression in human colorectal tumors. 230
A transcriptomic profile predicts clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 230
Cellular pharmacology of gemcitabine. 218
RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 212
MOLECULAR CHARACTERIZATION OF ESTABLISHED HUMAN COLON CARCINOMA CELL LINES (HCT-8) MADE RESISTANT TO 5-FLUOROURACIL BY DIFFERENT SELECTION SCHEDULES 206
Fluoropyrimidine-related toxicity in gastrointestinal cancer patients. Assessment of risk factors. 200
Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression 199
Stable disease in a patient with metastatic leiomyosarcoma treated with trabectedin 196
Cytotoxicity and DNA binding properties of a chloro glycylhistidinate gold(III) complex (GHAu). 190
D13Global gene expression profile reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 189
Global gene expression profile reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 186
Trabectedin in combination with pegylated liposomal doxorubicin in patients with ovarian tumors 185
Gender-related health in tuscany 178
Ertapenem peritoneal fluid concentrations in adult surgical patients. 176
Increased levels of CA 125 and CA 19·9 serum tumour markers following cyclic combined hormone replacement therapy 173
Adverse drug reactions in oncoLogy: intEnsive monitoring program on drug toXicity of biotechnological medicatioNs anD taRget therapies in Oncologic patientS - the ALEXANDROS observational study 172
Azithromycin concentrations in serum and bronchial secretions of patients with cystic fibrosis 172
Amoxicillin/clavulanic acid versus cefotaxime for antimicrobial prophylaxis in abdominal surgery: a randomized trial. 172
Retrospective analysis of 77 patients with ovarian cancer undergoing genetic testing for BRCA1 and BRCA2 mutations 172
Cytotoxicity, DNA damage, and cell cycle perturbations induced by two representative gold(III) complexes in human leukemic cells with different cisplatin sensitivity 171
Cytotoxic effects of gold(III) complexes on established human tumor cell lines sensitive and resistant to cisplatin 169
The most appropriate therapeutic strategy for acute lower respiratory tract infections: a Delphi-based approach. 169
5-methyltetrahydrofolate (mTHF) induces monocytes differentiation in HL60 cells 168
Conclusions. Role of the oral Beta-lactams in the treatment of exacerbations of chronic bronchitis: critical analysis and therapeutics recommendations 168
Identification of potential pharmacogenomic markers of clinical efficacy of 5-fluorouracil in colorectal cancer 167
The difficulties of polytherapy: examples from antimicrobial chemotherapy 167
Chromosomal characterization of methotrexate-resistant human T-lymphoblast leukemia cells (CCRF-CEM) with impaired polyglutamylation. 164
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphisms in primary colorectal cancer patients 163
Identification of pharmacogenomic markers of 5-fluorouracil-based chemotherapy in colorectal cancer 161
Differential inhibitory effects on human endometrial carcinoma cell growth of luteinizing hormone-releasing hormone analogues. 160
Betalactam therapy and intestinal flora. 159
Adverse effects of macrolide antibacterials. 158
[Plasma and tissue antibiotic concentrations: what is their prognostic value?] 156
Methicillin-resistant Staphylococcus aureus infections: A review of the currently available treatment options 156
5-methyltetrahydrofolate (MeTHF) enhances fluoropyrimidine cytotoxicity against human leukemia cells in vitro 154
Concentration of moxifloxacin in plasma and tonsillar tissue after multiple administration in adult patients. 154
Gold(III) Complexes with Bipyridyl Ligands: Solution Chemistry, Cytotoxicity and DNA Binding Properties 153
In vivo pharmacodynamic evaluation of clarithromycin in comparison to erythromycin. 153
Adjuvant therapy of colorectal carcinoma with 5-fluorouracil (5-FU) and l-folinic acid (l-LV) alone or combined with levamisole (LEV) or interferon alpha2a (IFN alpha2a). Preliminary toxicological results of a multicenter study of the Gruppo Oncologico-Chirurgico Cooperativo Italiano (GOCCI) 152
ADVANCED COLORECTAL CANCER (ACRC) IN ELDERLY PATIENTS: EVALUATION OF THREE DIFFERENT OXALIPLATIN-BASED CHEMOTHERAPY REGIMENS - Session D: Colo-rectal Cancer 152
Antimicrobial prophylaxis in prosthetic joint implant surgery: a comparative multicenter trial between teicoplanin and cefazolin 151
Evaluation of methotrexate (MTX) sensitivity by an ATP bioluminescence assay in human leukemia cells 150
Cationic lipids improve antisense oligonucleotide uptake and prevent degradation in cultured cells and in human serum 150
Gold(III) complexes as potential antitumor agents: solution chemistry and cytotoxic properties of some selected gold(III) compounds. 150
Marked variation thymidylate synthase (TS) and folylpolyglutamate synthetase (FPGS) gene expression in human colorectal cancer 149
Quantitative analysis by polymerase chain reaction (PCR) of genes involved in resistance to cytotoxic antimetabolites 149
Phase I clinical trial of a new alkylating agent, PTT-119 148
Pharmacokinetics of melphalan (L-PAM) during hyperthermic perfusion in patients with melanoma of the limbs 148
Pharmacokinetics and endocrine effects of leuprolide depot in advanced prostatic cancer: a dose-response analysis 147
The penetration of intramuscular cefotetan disodium into human extravascular fluid and maternal milk secretion. 147
Adjuvant therapy of colorectal carcinoma with 5-fluorouracil (5-FU) and l-folinic acid (l-LV) alone or with levamisole (LEV) or interferon alpha2a (IFN alpha2a). 146
Pharmacokinetic and pharmacodynamic aspects of antimicrobial agents for the treatment of uncomplicated urinary tract infections. 146
Pharmacological rationale for antibiotic treatment of intra-abdominal infections. 145
Induction of differentiation of HL-60 cells along the monocytic pathway by 5-methyltetrahydrofolate. 145
Comparative pharmacokinetic evaluation of ceftriaxone and cefotaxime in coincidence for short-term antimicrobial prophylaxis in surgery 144
Antimicrobial chemoimmunoprophylaxis in colorectal surgery with cefotetan and thymostimulin: prospective, controlled multicenter study. Italian Study Group on Antimicrobial Prophylaxis in Abdominal Surgery. 144
The pharmacokinetics and pharmacodynamics of the carbapenems: focus on doripenem 143
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphysms in primary colorectal cancer patients. 143
Analisi cariologica di linee cellulari leucemiche umane CCRF-CEM resistenti al metotressato (MTX) per alterata poliglutammilazione. 143
Enhancement of fluoropyrimidine cytotoxicity by 5-methyltetrahydrofolate in a human leukemia cell line, CCRF-CEM. 142
Pharmacokinetic evaluation of meropenem and imipenem in critically-ill patients with sepsis. 142
Identification of pharmacogenomic markers of 5-fluorouracil-based chemotherapy in colorectal cancer 142
Pharmacokinetics, endocrine and antitumour effects of leuprolide depot (TAP-144-SR) in advanced prostatic cancer: a dose-response evaluation. 141
Therapeutic recommendations of the multidisciplinary group. 140
Mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1 139
Quantitation of intratumoral thymidylate synthase (TS) and folylpolyglutamate synthetase (FPGS) gene expression by the Polymerase Chain Reaction (PCR): marked variation among human colorectal cancer patients 139
Adjuvant therapy of colorectal carcinoma with 5-fluorouracil and l-folinic acid alone or combined with levamisole or interferon-alfa2a. Preliminary toxicological results of a multicenter study of the Italian Cooperative Oncological-Surgical Group (GOCCI) 139
Intra-arterial chemotherapy with 5-fluorouracil and 5-methyltetrahydrofolate in the treatment of unresectable liver metastases from colorectal cancer 139
Comparative in vitro activity of the new oxazolidinones DuP 721 and DuP 105 against staphylococci and streptococci. 139
Comparative in vitro activity of ciprofloxacin against methicillin-resistant staphylococci 138
Biochemical modulation of fluoropyrimidines by antifolates and folates in an in vitro model of human leukemia. 137
Antibiotic-induced release of bacterial cell wall components in the pathogenesis of sepsis and septic shock: a review. 136
Linezolid pharmacokinetic/pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusion. 136
Efficacy of 3-(p-fluorofenyl)-L-alanyl-3-m-bis(2-chloroethyl)amino-phenyl-L-methionine ethoxy HCl (PTT-119) on human leukemia cell lines 136
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphisms in primary colorectal cancer patients 135
Pharmacological aspects of the antibiotics used for urological diagnostic procedures 135
Farmacologia degli antibiotici nelle infezioni della cute e dei tessuti molli 135
Pharmacokinetics and blister fluid penetration of ticarcillin/clavulanate in adults 134
Etiology issues and problems of antibiotic resistance 134
Pharmacokinetics of oral medroxyprogesterone acetate at moderate doses. 133
Bacampicillin and talampicillin serum and urinary levels when the two antibiotics have been given orally at equimolar doses of ampicillin 133
Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers 133
Amikacin in obstetric, gynecologic, and neonatal infections: laboratory and clinical studies. 133
Phase I trial of a novel alkylating agent 132
Pharmacokinetics of dirithromycin in patients with mild or moderate cirrhosis 132
Combination chemotherapy with cyclophosphamide, fluorouracil, and either epirubicin or mitoxantrone: a comparative randomized multicenter study in metastatic breast carcinoma. 132
Totale 17.471
Salva come PNG Salva come JPEG
Categoria #
all - tutte 103.598
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 103.598
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021173 0 0 0 0 0 0 0 0 0 0 0 173
2021/20221.481 33 212 45 95 45 45 47 110 58 34 315 442
2022/20234.514 404 491 145 426 465 919 618 279 516 27 128 96
2023/20241.648 98 187 346 84 117 235 67 337 21 63 42 51
2024/202511.429 471 1.226 679 1.694 3.212 1.601 167 550 650 244 443 492
2025/202610.843 1.401 1.940 1.257 1.117 1.184 392 1.366 541 753 564 263 65
Totale 37.567